PDL BIOPHARMA, INC. - 69329Y104
Sector:
Healthcare
· Industry:
Biological Products, (No Diagnostic Substances)
Website:
No information yet
· Social:
No information yet
Company profile
Description is not available for this instrument yet.
Quarter snapshot
Latest / Compare
Q1 2026
· Q4 2025
Value (USD)
Total reported value ($000)
$28K
QoQ value delta ($000)
+$1K
(+3.7%)
Implied price effect (QoQ)
+244.46%
Shares
Total shares
55,079
QoQ shares delta
-127,869
(-69.89%)
Total shares held by funds (by quarter)
Top holders (Q1 2026)
Top 25 only
Full list
Partial Q1 2026 data: 6 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| Diversified Trust Co | 27 | 11,554 | 0.0% |
| RHUMBLINE ADVISERS | 1 | 612 | 0.0% |
| Westside Investment Management, Inc. | 0 | 500 | 0.0% |
| Argent Trust Co | 0 | 41,405 | 0.0% |
| Financial Gravity Asset Management, Inc. | 0 | 33 | 0.0% |
| Motiv8 Investments LLC | 0 | 875 | 0.0% |
| Murphy & Mullick Capital Management Corp | 0 | 100 | 0.0% |